EVERSION
It develops medtech aimed at identifying and addressing foot pain linked to shoes, with an AI-focused positioning in healthcare.
Overview
EVERSION is a German medtech company focused on tackling pain associated with shoes, positioning its work within AI-enabled healthcare. Its offering appears targeted at people experiencing foot or shoe-related pain, as well as the clinical or consumer health channels that address mobility and comfort issues. The company’s differentiator is its focus on pain that can be hidden or overlooked in everyday footwear. EVERSION has raised about $2M across one undisclosed round, reported as €2.3M, to advance its product and market development.
Funding History
German medtech EVERSION raises €2.3M to tackle the pain hiding in your shoes
Frequently Asked Questions
- How much has EVERSION raised in total?
- EVERSION has raised a total of $2M across 1 funding round.
- What does EVERSION do?
- EVERSION is a German medtech company focused on tackling pain associated with shoes, positioning its work within AI-enabled healthcare. Its offering appears targeted at people experiencing foot or shoe-related pain, as well as the clinical or consumer health channels that address mobility and comfort issues. The company’s differentiator is its focus on pain that can be hidden or overlooked in everyday footwear. EVERSION has raised about $2M across one undisclosed round, reported as €2.3M, to advance its product and market development.
- Where is EVERSION headquartered?
- EVERSION is headquartered in San Francisco, CA.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.